SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about approval of products

16 Apr 2021 Evaluate

Vivimed Labs has informed that it received approvals for the following 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site: Bilastine tablets 20mg under brand name FLUSTIN; Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI; and Paracetamol 12Smg/ Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

7.70 -0.09 (-1.16%)
20-Apr-2026 14:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1233.20
Cipla 1232.00
Zydus Lifesciences 937.70
Lupin 2327.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×